Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Frequency of Igg Anti-Varicella and Anti-Rubella Antibodies in Female Students of Shiraz University of Medical Sciences, Iran Publisher



Hashemi SMA1 ; Alipour AH1, 2 ; Khatab Z1 ; Maleki S1 ; Nekooei F1 ; Dashtizadeh F1 ; Daryabor GR3 ; Kalantar K3, 4 ; Salimi V5 ; Sarvari J1, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Teheran, Iran
  3. 3. Autoimmune Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4. Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Department of Virology, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Infezioni in Medicina Published:2023


Abstract

Background: As infection with rubella and varicella-zoster viruses (VZV) can lead to congenital syndrome and its dangerous complications, assessing immunity to these congenital infections can represent the biologi-cal risk assessment related to their exposure in high-risk groups. Therefore, we aimed to evaluate the frequency of IgG anti-varicella/rubella antibodies (Abs) in female students at Shiraz University of Medical Sciences (SUMS), Iran. Patients and Methods: In this study, a total of 434 female students were included. Sera were isolated from blood samples and stored at-20°C for later analysis. A questionnaire form was documented and contained demo-graphic data as well as the history of vaccinations. Enrolled students were divided into recipients of either one or two doses of the measles/rubella (MR) vaccine. Serum samples were analyzed for rubella and VZV IgG Abs using commercial IgG immunoassays. Results: The students were 21.6±4.25 years old on aver-age. Out of the 434 enrolled students, 292 (67.3%) and 287 (66.1%) students were positive for anti-varicella and anti-rubella IgG-Abs, respectively. The frequency of anti-rubella IgG Ab was significantly higher in those who received one dose of MR vaccine (P<0.001). In ad-dition, 205 (47.2%) and 59 (13.6%) students were dou-ble-positive (anti-varicella/rubella IgG Abs) and dou-ble-negative, respectively. Conclusion: Our results indicated that an additional dose of rubella vaccine may be required for those who received two doses of the vaccine. In addition, we rec-ommend the inclusion of the VZV vaccine in Iran’s routine vaccination program. Further studies are recom-mended to verify these results. © 2023, EDIMES Edizioni Medico Scientifiche. All rights reserved.